Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: dilaudid attending: chief complaint: ventral hernia major surgical or invasive procedure: umbilical and ventral hernia repair history of present illness: 30yo female currently on hd, had pd catheter removed in , with ongoing complaint of pain from an umbilical hernia. past medical history: - esrd since , currently on hd via tunneled line - peritonitis - type i dm complicated by neuropathy and nephropathy - bilateral cataract surgeries - ventral hernia social history: - lives with her mother, + tobacco history, social etoh, marijuana use noted in history family history: dm type ii, otherwise nc physical exam: upon admission: gen - nad, aox3 cv - rrr, s1/s2 appreciated chest - ctab abdomen - soft, nontender, nondistended, well healed pd cath removal site left abdomen, normal bowel sounds ext - no c/c/e pertinent results: upon admission: wbc-7.9 rbc-3.72* hgb-10.9* hct-34.8* mcv-94 mch-29.2 mchc-31.2 rdw-18.1* plt ct-239 glucose-78 urean-21* creat-6.4*# na-144 k-3.6 cl-104 hco3-30 angap-14 calcium-8.4 phos-3.3 mg-2.1 07:30am blood wbc-7.1 rbc-3.83* hgb-11.4* hct-36.3 mcv-95 mch-29.9 mchc-31.5 rdw-17.8* plt ct-253 04:40am blood glucose-122* urean-20 creat-8.5*# na-140 k-3.9 cl-100 hco3-24 angap-20 brief hospital course: the patient was admitted to the west-1 surgery for scheduled ventral/umbilical herniorrhaphy on , which went well without complication (please refer to operative note for details). in the pacu, the patient experienced significant pain control issues as well as nausea and emesis. after stabilization and improvement in symptoms, the patient was transferred to the inpatient floor in stable condition. neuro: the patient received dilaudid with adequate pain control, however patient experienced nausea likely related to narcotic analgesia. she was transitioned to oxycodone during her admission after improvement in surgical site pain. cv: the patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. pulmonary: the patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. good pulmonary toilet, early ambulation and incentive spirrometry were encouraged throughout hospitalization. gi/gu/fen: post-operatively, diet was advanced when appropriate and tolerated. patient's intake and output were closely monitored, and iv fluid was adjusted when necessary. electrolytes were routinely followed, and repleted when necessary. patient underwent scheduled hemodialysis while an inpatient. id: the patient's white blood count and fever curves were closely watched for signs of infection. endocrine: post-operatively, the patient's blood sugar levels were monitored and a sliding scale implemented. hematology: the patient's complete blood count was examined routinely; no transfusions were required. prophylaxis: the patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible. at the time of discharge, the patient was doing well, afebrile with stable vital signs. the patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. the patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. medications on admission: carvedilol 12.5 mg , sensipar 30 mg tdaily, furosemide 60 mg daily, novolog 100 unit/ml solution per sliding scale qid, glargine 100 unit/ml solution 15 units qhs- fluctuates with appetite and blood sugars, lisinopril 20 mg daily, oxycodone 5 mg tablet every four (4) hours as needed for pain sevelamer hcl 800 mg tid with meals, travoprost (benzalkonium) 0.004 % drops 1 gtt ou hs, aspirin 81 mg daily, b complex vitamins daily, folic acid 1 mg daily, discharge medications: 1. carvedilol 12.5 mg tablet sig: one (1) tablet po bid (2 times a day). 2. cinacalcet 30 mg tablet sig: one (1) tablet po daily (daily). 3. furosemide 20 mg tablet sig: three (3) tablet po daily (daily). 4. lisinopril 20 mg tablet sig: one (1) tablet po daily (daily). 5. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po daily (daily). 6. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 7. b complex vitamins capsule sig: one (1) cap po daily (daily). 8. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 9. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. 10. latanoprost 0.005 % drops sig: one (1) drop ophthalmic hs (at bedtime). 11. sevelamer hcl 400 mg tablet sig: two (2) tablet po tid w/meals (3 times a day with meals). 12. oxycodone 5 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*30 tablet(s)* refills:*0* 13. insulin glargine 100 unit/ml solution sig: ten (10) units subcutaneous once a day. 14. novolog 100 unit/ml solution sig: follow sliding scale subcutaneous four times a day. 15. epogen 10,000 unit/ml solution sig: one (1) ml injection once a week. discharge disposition: home with service facility: dialysis discharge diagnosis: esrd ventral hernia repair discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: please call dr. office if you have any of the warning signs listed below. continue with your usual dialysis schedule no heavy lifting/straining no driving while you are taking pain medication followup instructions: provider: , md phone: date/time: 3:40 provider: , md phone: date/time: 10:40 provider: , md phone: date/time: 10:40 procedure: hemodialysis other and open repair of other hernia of anterior abdominal wall with graft or prosthesis other and open repair of umbilical hernia with graft or prosthesis diagnoses: end stage renal disease renal dialysis status polyneuropathy in diabetes hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled umbilical hernia without mention of obstruction or gangrene diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled ventral, unspecified, hernia without mention of obstruction or gangrene 

Answer: The patient is high likely exposed to